CHRS
Coherus BioSciences Inc
Price:  
1.78 
USD
Volume:  
711,610.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CHRS Relative Valuation

-922.9%
Upside

As of 2024-06-14, the Relative Valuation of Coherus BioSciences Inc (CHRS) is (14.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.78 USD, the upside of Coherus BioSciences Inc based on Relative Valuation is -922.9%.

The range of the Relative Valuation is (14.52) - (14.86) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.1x - 30.5x 29.3x
Forward P/E multiples 24.4x - 28.8x 27.4x
Fair Price (14.52) - (14.86) (14.65)
Upside -915.6% - -934.8% -922.9%
1.78 USD
Stock Price
(14.65) USD
Fair Price

CHRS Relative Valuation - Historical P/E Data

Date P/E
2024-06-13 -3.45
2024-06-12 -3.52
2024-06-11 -3.35
2024-06-10 -3.37
2024-06-07 -3.27
2024-06-06 -3.37
2024-06-05 -3.50
2024-06-04 -3.45
2024-06-03 -3.41
2024-05-31 -3.52
2024-05-30 -3.64
2024-05-29 -3.56
2024-05-28 -3.64
2024-05-24 -3.70
2024-05-23 -3.89
2024-05-22 -4.08
2024-05-21 -4.03
2024-05-20 -4.03
2024-05-17 -4.10
2024-05-16 -4.20
2024-05-15 -4.22
2024-05-14 -4.03
2024-05-13 -4.05
2024-05-10 -3.68
2024-05-09 -4.10
2024-05-08 -4.32
2024-05-07 -4.35
2024-05-06 -4.30
2024-05-03 -4.39
2024-05-02 -4.20
2024-05-01 -3.99
2024-04-30 -3.79
2024-04-29 -4.01
2024-04-26 -3.95
2024-04-25 -3.74
2024-04-24 -3.91
2024-04-23 -4.22
2024-04-22 -4.22
2024-04-19 -4.01
2024-04-18 -3.87
2024-04-17 -4.16
2024-04-16 -4.16
2024-04-15 -4.26
2024-04-12 -4.32
2024-04-11 -4.66
2024-04-10 -4.74
2024-04-09 -4.78
2024-04-08 -4.86
2024-04-05 -4.70
2024-04-04 -4.51